MedPath

Effects of Deepure(Pu-erh Tea Extract) on Glycemic Control

Not Applicable
Conditions
Glucose Metabolism Disorders
Interventions
Dietary Supplement: Deepure
Registration Number
NCT03613688
Lead Sponsor
Tasly Pharmaceuticals, Inc.
Brief Summary

This is a randomized, controlled, cross-over study on the effects of consumption of Deepure puerh tea extract (PTE) on glucose tolerance and metabolic markers.

Detailed Description

The study will involve consuming three different doses: 1 gram, 1.5 grams, and 2 grams, and will be given in warm water, with a bland meal. The effects on glucose and insulin after consumption will be evaluated.The subjects will be randomly assigned to one of four groups with different sequences.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
28
Inclusion Criteria
  • Men and women;
  • Aged 18-70 years;
  • BMI between 20-30;
  • Fasting blood glucose at screening between 71-125 mg/dL. both inclusive.
Exclusion Criteria
  • Taking dietary supplements judged to interfere with the effects of Deepure on glucose metabolism (for example: cinnamon extract; chromium picolinate; mulberry extract; bitter melon extract, green tea extracts, black tea extracts, pu-erh tea);
  • Participation in other clinical trials, involving an investigational product or lifestyle change, during the last month;
  • Participation in another research study during this trial, involving an investigational product or lifestyle change; Taking prescription medication known to affect glucose metabolism;
  • Taking over-the-counter medication known to affect glucose metabolism;
  • Drinking 3 or more cups of tea daily;
  • Unwilling to abstain from drinking tea for 24 hours before clinic visits; (if a person drinks tea within 24 hours of a clinic visit, the person's visit will be re-scheduled);
  • Consuming 2 or more drinks of alcohol per day;
  • Unwilling to abstain from drinking alcohol for 10 hours before clinic visits;
  • Diagnosed with diabetes Type I; Taking medication for diabetes Type II;
  • Diagnosed with the thyroid disorder Hashimoto's disease;
  • Past major surgery to your stomach or intestines (minor surgery not a problem such as hernia repair, appendix removal, gallbladder removal);
  • Currently taking cholesterol-lowering medication (for example: statins);
  • Currently taking coumadin;
  • Major trauma within the past 6 months;
  • Major surgery within the past 6 months;
  • Severe chronic infectious disease (such as HIV, chronic hepatitis);
  • Active depression;
  • Self-reported eating disorders;
  • History of drug abuse during past two years;
  • Currently going through intense stressful events or life changes;
  • Women of child-bearing potential: Pregnant, breast-feeding, or trying to become pregnant;
  • Women of child-bearing potential: Not using effective contraception;
  • Food allergies or sensitivities to tea.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Deepure Group BDeepureVisit 3: Warm water with 1 g Deepure; Visit 4: Warm water with 1.5 g Deepure; Visit 5: Warm water with 2 g Deepure; Visit 6: Warm water without Deepure.
Deepure Group CDeepureVisit 3: Warm water with 1.5 g Deepure; Visit 4: Warm water with 2 g Deepure; Visit 5: Warm water without Deepure; Visit 6: Warm water with 1 g Deepure.
Deepure Group DDeepureVisit 3: Warm water with 2 g Deepure; Visit 4: Warm water without Deepure; Visit 5: Warm water with 1 g Deepure; Visit 6: Warm water with 1.5 g Deepure.
Deepure Group ADeepureVisit 3: Warm water without Deepure; Visit 4: Warm water with 1 g Deepure; Visit 5: Warm water with 1.5 g Deepure; Visit 6: Warm water with 2 g Deepure.
Primary Outcome Measures
NameTimeMethod
Post-prandial glucose responseFrom baseline to 30, 60, 90, 120, and 180 minutes

Change in blood glucose leve after consuming test meal with and without Pu'er tea

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

NIS labs

🇺🇸

Klamath Falls, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath